Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on April 25, 2025
Martina Announces Proposed Acquisition of 7303 Warden Inc.
GlobeNewswire
·
April 25, 2025
TORONTO, April 25, 2025 (GLOBE NEWSWIRE) -- Martina Minerals Corp. (the “Company”) (TSXV: MTN.H) is pleased to announce that it has entered into a non-binding letter of intent (the “LOI”) on April 24, 2025, with 7303 Warden Inc. (“7303”), a non-arm’s …
Rezolute, Inc. Announces Closing of Underwritten Offering
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel, transformative therapies for serious rare diseases, today announced the closing …
CloudDefense.AI Reveals How Artificial Intelligence is Revolutionizing Threat Detection in the Cloud
EIN Presswire
·
April 25, 2025
PALO ALTO, CA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- In a world where cloud breaches are making headlines every other week, relying on outdated security tools is no longer an option. CloudDefense.AI is spotlighting the growing role of …
Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting
GlobeNewswire
·
April 25, 2025
SALT LAKE CITY, April 25, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced new clinical data will be shared at the American Association for Cancer Research (AACR) …
Prelude Announces Presentations at 2025 AACR Annual Meeting
GlobeNewswire
·
April 25, 2025
Preclinical data elucidating the mechanism of action of PRT3789, Prelude’s first-in-class, highly selective SMARCA2 degrader currently in early clinical development Highlights from Prelude’s efforts to discover and develop selective KAT6A degraders, …
AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance
GlobeNewswire
·
April 25, 2025
IRVINE, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications …
StoryboardHero Unveils Major Image Quality Upgrade with Latest AI Models
EIN Presswire
·
April 25, 2025
Singapore-based storyboard generator promises enhanced character consistency and visual fidelity for filmmakers and content creators SINGAPORE, SINGAPORE, April 25, 2025 /EINPresswire.com/ -- StoryboardHero, the AI-powered storyboard generation platform …
Prehost.com Releases Technical Analysis on Web Hosting's Impact on SEO Performance
EIN Presswire
·
April 25, 2025
Experts reveal why your choice of hosting provider can make—or break—your search‐ranking and user experience CA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- In today’s ultra-competitive digital landscape, businesses often focus on content, …
Spanios and White Lion Capital LLC Announce Strategic Partnership to Accelerate Drug Development
GlobeNewswire
·
April 25, 2025
HOUSTON, April 25, 2025 (GLOBE NEWSWIRE) -- Spanios, a leader in human-derived organoid model systems, is pleased to announce a strategic partnership with White Lion Capital LLC. This collaboration empowers biotech and pharma companies to leverage Spanios’ …
Discovery Announces Management Appointments
GlobeNewswire
·
April 25, 2025
TORONTO, April 25, 2025 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) is pleased to announce the following management appointments: Pierre Rocque as Chief Operating Officer; Jennifer Wagner as Executive …
Tevogen Bio Announces 2025 Annual Meeting
GlobeNewswire
·
April 25, 2025
WARREN, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen Bio” or “Company”) (Nasdaq: TVGN) today announced that the Company will hold its 2025 annual meeting of stockholders (the “Annual Meeting”) via live webcast at 11 a.m. …
Ecocyclic and enespa Partner to Launch State-of-the-Art Recycling Facility in Winnie, Texas
EIN Presswire
·
April 25, 2025
Ecocyclic and enespa join forces to build a high-tech chemical recycling plant in Texas, turning plastic waste into sustainable, circular raw materials WINNIE, TX, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Ecocyclic, a Texas-based …
N2 Infotech commercializes AI-based elevator predictive maintenance solution: Expanding market on public institutions
EIN Presswire
·
April 25, 2025
N2 Infotech rolls out an AI-based elevator maintenance system that targets public institutions with smart, usage-based predictive tech for global expansion. PANGYO, GYEONGGI-DO, SOUTH KOREA, April 25, 2025 /EINPresswire.com/ -- A predictive maintenance …
iMyFone MirrorTo Enhances Mobile-to-PC Screen Mirroring for Professionals, Educators, and Gamers
EIN Presswire
·
April 25, 2025
NY, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- iMyFone has announced improvements to MirrorTo, its cross-platform screen mirroring solution that enables users to connect and control Android and iOS devices from their PC or Mac. Designed for …
Introducing the ELECFREAKS micro:bit Nezha Pro Sports Kit: Bringing Robotics to Life Through Play
EIN Presswire
·
April 25, 2025
ELECFREAKS Nezha Pro Sports Kit: Build …
HPQ Silicium : Correction de communiqués antérieurs
GlobeNewswire
·
April 25, 2025
En réponse à une demande formulée par l’Autorité des marchés financiers, HPQ Silicium procède à la publication d’un communiqué rectificatif visant à corriger certaines informations à caractère prospectif diffusées dans des communiqués antérieurs. MONTRÉAL, …
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC
GlobeNewswire
·
April 25, 2025
Gene signatures associated with increased efficacy of micvotabart pelidotin (MICVO) due to greater linker cleavage were identified based on differential gene expression analysis of PDX responders/non-responders Mouse analog of MICVO in a syngeneic model …
AGII Refines Blockchain Speed With Real-Time Smart Contract Logic
EIN Presswire
·
April 25, 2025
Enhancing Web3 Through Instantaneous Execution and Scalable Contract Automation SEATTLE, WA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- AGII, the intelligent Web3 platform powered by advanced AI, announced a breakthrough refinement in smart …
Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
April 25, 2025
PARAMUS, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today the presentation of positive data …
ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma
GlobeNewswire
·
April 25, 2025
- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus rituximab and lenalidomide (R2) was well-tolerated and demonstrated promising anti-tumor activity - Combination …